Stocks · News reference
Filed: 2026-11-04 AccNo: 0001014739-26-000028 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
McKesson Corporation and private equity firm Clayton, Dubilier & Rice have engaged Wall Street banks to arrange $3.1 billion in financing for their acquisition of Option Care Health.
Option Care Health announced its financial results for the third quarter ended September 30, 2026, reporting growth in revenue and net income while noting the withdrawal of financial guidance due to a pending acquisition.
Option Care Health, Pacira Biosciences and HealthStream show overbought RSI levels above 83, warning momentum-focused investors.
Major M&A deals this week include Viatris buys Pacira BioSciences, TowneBank acquires blueharbor, Energy Transfer buys Vacquero Midstream.
UBS analyst A.J. Rice downgrades Option Care Health (NASDAQ:OPCH) from Buy to Neutral and lowers the price target from $39 to $32.05.
William Blair analyst Matt Larew downgrades Option Care Health (NASDAQ:OPCH) from Outperform to Market Perform.